Shocking details emerge: Matthew Perry spent $55K on Ketamine before his death

The unsealed documents offer a chilling timeline of events leading up to Matthew Perry's passing.


Pop Culture & Art August 19, 2024
Shocking details emerge: Matthew Perry spent $55K on Ketamine before his death

Newly unsealed court documents in the case against Matthew Perry's live-in assistant, Kenny Iwamasa, have shed light on the extent of the actor's ketamine use prior to his tragic death in October 2023. The documents reveal that Perry and Iwamasa allegedly spent at least $55,000 on 55 vials of ketamine and numerous injections in just 29 days.

Text messages from Iwamasa show a near-daily pattern of requests for more ketamine, sometimes even engaging in illegal drug deals in the early morning hours. The records also detail how Perry and Iwamasa met with a doctor known as "Dr. P." in parking lots for ketamine injections, exchanging thousands of dollars in cash for the drug.

Disturbingly, Dr. P. reportedly visited Perry's house on multiple occasions to administer injections, even once within hours of Perry receiving a ketamine infusion treatment, leading to an adverse reaction.

The documents also allege that Iwamasa illegally purchased 25 vials of ketamine for $6,000 just nine days after a previous purchase of the same amount. He then allegedly injected Perry six times that same day, and at least 18 more times over the next 72 hours. On the day of his death, Iwamasa reportedly injected Perry at least three more times.

Iwamasa, along with Dr. P., Jasveen Sangha (known as "the Ketamine Queen"), Dr. Mark Chavez, and Erik Fleming have all been charged in connection with Perry's death. Iwamasa has pleaded guilty to one count of conspiracy to distribute ketamine causing death.

The unsealed documents offer a chilling timeline of events leading up to Perry's passing, highlighting the devastating consequences of addiction and the illegal drug trade.

COMMENTS

Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ